Skip to main content
NCBI home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1995 Apr;8(2):260–267. doi: 10.1128/cmr.8.2.260

Measles control in the United States: problems of the past and challenges for the future.

D L Wood 1, P A Brunell 1
PMCID: PMC172858  PMID: 7621401

Abstract

Elimination of indigenous measles from the United States has been a public priority since 1978. To assess the progress made toward this goal, we review the epidemiology of measles from 1963 to the present. From the 1970s through early into the recent measles epidemic, the majority of measles cases were in highly vaccinated, school-age children. This was due primarily to a 1 to 5% primary measles-mumps-rubella vaccine failure rate and nonrandom mixing patterns among school-age populations. To eliminate susceptible individuals in the school-age populations, a second dose of measles vaccine is now recommended between 5 and 6 years or 11 and 12 years by both the Advisory Committee on Immunization Practices and the American Academy of Pediatrics. Later in the epidemic, measles cases surged among unimmunized preschool children, especially among the poor in inner-city areas. Immunization rates have been documented to be low among preschool populations because of missed opportunities to administer vaccines at all health visits and barriers to access to immunizations. To raise immunization rates, the age for the first measles-mumps-rubella immunization was lowered to 12 to 15 months of age, federal immunization funding has increased, and new standards for immunization delivery have been developed and promulgated.

Full Text

The Full Text of this article is available as a PDF (214.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaby P., Samb B., Simondon F., Whittle H., Seck A. M., Knudsen K., Bennett J., Markowitz L., Rhodes P. Child mortality after high-titre measles vaccines in Senegal: the complete data set. Lancet. 1991 Dec 14;338(8781):1518–1519. doi: 10.1016/0140-6736(91)92330-5. [DOI] [PubMed] [Google Scholar]
  2. Albrecht P., Ennis F. A., Saltzman E. J., Krugman S. Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J Pediatr. 1977 Nov;91(5):715–718. doi: 10.1016/s0022-3476(77)81021-4. [DOI] [PubMed] [Google Scholar]
  3. Andersen R. M., McCutcheon A., Aday L. A., Chiu G. Y., Bell R. Exploring dimensions of access to medical care. Health Serv Res. 1983 Spring;18(1):49–74. [PMC free article] [PubMed] [Google Scholar]
  4. Andersen R., Lewis S. Z., Giachello A. L., Aday L. A., Chiu G. Access to medical care among the Hispanic population of the southwestern United States. J Health Soc Behav. 1981 Mar;22(1):78–89. [PubMed] [Google Scholar]
  5. Anderson R. M., May R. M. Vaccination against rubella and measles: quantitative investigations of different policies. J Hyg (Lond) 1983 Apr;90(2):259–325. doi: 10.1017/s002217240002893x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Arnold P. J., Schlenker T. L. The impact of health care financing on childhood immunization practices. Am J Dis Child. 1992 Jun;146(6):728–732. doi: 10.1001/archpedi.1992.02160180088023. [DOI] [PubMed] [Google Scholar]
  7. Atkinson W. L., Orenstein W. A., Krugman S. The resurgence of measles in the United States, 1989-1990. Annu Rev Med. 1992;43:451–463. doi: 10.1146/annurev.me.43.020192.002315. [DOI] [PubMed] [Google Scholar]
  8. Bishai D. M., Bhatt S., Miller L. T., Hayden G. F. Vaccine storage practices in pediatric offices. Pediatrics. 1992 Feb;89(2):193–196. [PubMed] [Google Scholar]
  9. Bobo J. K., Gale J. L., Thapa P. B., Wassilak S. G. Risk factors for delayed immunization in a random sample of 1163 children from Oregon and Washington. Pediatrics. 1993 Feb;91(2):308–314. [PubMed] [Google Scholar]
  10. Brunell P. A. Measles one more time. Pediatrics. 1990 Sep;86(3):474–478. [PubMed] [Google Scholar]
  11. Brunell P. A. Measles vaccine--one or two doses? Pediatrics. 1988 May;81(5):722–724. [PubMed] [Google Scholar]
  12. Brunell P. A., Novelli V. M., Lipton S. V., Pollock B. Combined vaccine against measles, mumps, rubella, and varicella. Pediatrics. 1988 Jun;81(6):779–784. [PubMed] [Google Scholar]
  13. Brunell P. A., Weigle K., Murphy M. D., Shehab Z., Cobb E. Antibody response following measles-mumps-rubella vaccine under conditions of customary use. JAMA. 1983 Sep 16;250(11):1409–1412. [PubMed] [Google Scholar]
  14. Chui L. W., Marusyk R. G., Pabst H. F. Measles virus specific antibody in infants in a highly vaccinated society. J Med Virol. 1991 Mar;33(3):199–204. doi: 10.1002/jmv.1890330311. [DOI] [PubMed] [Google Scholar]
  15. Crawford G. E., Gremillion D. H. Epidemic measles and rubella in air force recruits: impact of immunization. J Infect Dis. 1981 Nov;144(5):403–410. doi: 10.1093/infdis/144.5.403. [DOI] [PubMed] [Google Scholar]
  16. Currier R. W., 2nd, Hardy G. E., Jr, Conrad J. L. Measles in previously vaccinated children. Evaluation of an outbreak. Am J Dis Child. 1972 Dec;124(6):854–857. doi: 10.1001/archpedi.1972.02110180056007. [DOI] [PubMed] [Google Scholar]
  17. Cutts F. T., Henderson R. H., Clements C. J., Chen R. T., Patriarca P. A. Principles of measles control. Bull World Health Organ. 1991;69(1):1–7. [PMC free article] [PubMed] [Google Scholar]
  18. Cutts F. T. Measles control in young infants: where do we go from here? Lancet. 1993 Jan 30;341(8840):290–291. doi: 10.1016/0140-6736(93)92629-8. [DOI] [PubMed] [Google Scholar]
  19. Cutts F. T., Zell E. R., Mason D., Bernier R. H., Dini E. F., Orenstein W. A. Monitoring progress toward US preschool immunization goals. JAMA. 1992 Apr 8;267(14):1952–1955. [PubMed] [Google Scholar]
  20. Dales L. G., Kizer K. W., Rutherford G. W., Pertowski C. A., Waterman S. H., Woodford G. Measles epidemic from failure to immunize. West J Med. 1993 Oct;159(4):455–464. [PMC free article] [PubMed] [Google Scholar]
  21. Davis R. M., Whitman E. D., Orenstein W. A., Preblud S. R., Markowitz L. E., Hinman A. R. A persistent outbreak of measles despite appropriate prevention and control measures. Am J Epidemiol. 1987 Sep;126(3):438–449. doi: 10.1093/oxfordjournals.aje.a114675. [DOI] [PubMed] [Google Scholar]
  22. Edmonson M. B., Addiss D. G., McPherson J. T., Berg J. L., Circo S. R., Davis J. P. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA. 1990 May 9;263(18):2467–2471. [PubMed] [Google Scholar]
  23. Ewert D. P., Thomas J. C., Chun L. Y., Enguidanos R. C., Waterman S. H. Measles vaccination coverage among Latino children aged 12 to 59 months in Los Angeles County: a household survey. Am J Public Health. 1991 Aug;81(8):1057–1059. doi: 10.2105/ajph.81.8.1057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Farizo K. M., Stehr-Green P. A., Markowitz L. E., Patriarca P. A. Vaccination levels and missed opportunities for measles vaccination: a record audit in a public pediatric clinic. Pediatrics. 1992 Apr;89(4 Pt 1):589–592. [PubMed] [Google Scholar]
  25. Garenne M., Leroy O., Beau J. P., Sene I. Child mortality after high-titre measles vaccines: prospective study in Senegal. Lancet. 1991 Oct 12;338(8772):903–907. doi: 10.1016/0140-6736(91)91771-l. [DOI] [PubMed] [Google Scholar]
  26. Gindler J. S., Atkinson W. L., Markowitz L. E. Update--the United States measles epidemic, 1989-1990. Epidemiol Rev. 1992;14:270–276. doi: 10.1093/oxfordjournals.epirev.a036090. [DOI] [PubMed] [Google Scholar]
  27. Gustafson T. L., Lievens A. W., Brunell P. A., Moellenberg R. G., Buttery C. M., Sehulster L. M. Measles outbreak in a fully immunized secondary-school population. N Engl J Med. 1987 Mar 26;316(13):771–774. doi: 10.1056/NEJM198703263161303. [DOI] [PubMed] [Google Scholar]
  28. Halsey N. A. Increased mortality after high titer measles vaccines: too much of a good thing. Pediatr Infect Dis J. 1993 Jun;12(6):462–465. doi: 10.1097/00006454-199306000-00002. [DOI] [PubMed] [Google Scholar]
  29. Hersh B. S., Markowitz L. E., Maes E. F., Funkhouser A. W., Baughman A. L., Sirotkin B. I., Hadler S. C. The geographic distribution of measles in the United States, 1980 through 1989. JAMA. 1992 Apr 8;267(14):1936–1941. [PubMed] [Google Scholar]
  30. Hethcote H. W. Measles and rubella in the United States. Am J Epidemiol. 1983 Jan;117(1):2–13. doi: 10.1093/oxfordjournals.aje.a113511. [DOI] [PubMed] [Google Scholar]
  31. Hilleman M. R., Buynak E. B., Weibel R. E., Stokes J., Jr, Whitman J. E., Jr, Leagus M. B. Development and evaluation of the Moraten measles virus vaccine. JAMA. 1968 Oct 14;206(3):587–590. [PubMed] [Google Scholar]
  32. Hutchins S. S., Escolan J., Markowitz L. E., Hawkins C., Kimbler A., Morgan R. A., Preblud S. R., Orenstein W. A. Measles outbreak among unvaccinated preschool-aged children: opportunities missed by health care providers to administer measles vaccine. Pediatrics. 1989 Mar;83(3):369–374. [PubMed] [Google Scholar]
  33. Hutchins S. S., Markowitz L. E., Mead P., Mixon D., Sheline J., Greenberg N., Preblud S. R., Orenstein W. A., Hull H. F. A school-based measles outbreak: the effect of a selective revaccination policy and risk factors for vaccine failure. Am J Epidemiol. 1990 Jul;132(1):157–168. doi: 10.1093/oxfordjournals.aje.a115627. [DOI] [PubMed] [Google Scholar]
  34. Jenks P. J., Caul E. O., Roome A. P. Maternally derived measles immunity in children of naturally infected and vaccinated mothers. Epidemiol Infect. 1988 Oct;101(2):473–476. doi: 10.1017/s095026880005442x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Kambarami R. A., Nathoo K. J., Nkrumah F. K., Pirie D. J. Measles epidemic in Harare, Zimbabwe, despite high measles immunization coverage rates. Bull World Health Organ. 1991;69(2):213–219. [PMC free article] [PubMed] [Google Scholar]
  36. King G. E., Markowitz L. E., Patriarca P. A., Dales L. G. Clinical efficacy of measles vaccine during the 1990 measles epidemic. Pediatr Infect Dis J. 1991 Dec;10(12):883–888. doi: 10.1097/00006454-199112000-00001. [DOI] [PubMed] [Google Scholar]
  37. Krugman R. D., Meyer B. C., Enterline J. C., Parkman P. D., Witte J. J., Meyer H. M., Jr Impotency of live-virus vaccines as a result of improper handling in clinical practice. J Pediatr. 1974 Oct;85(4):512–514. doi: 10.1016/s0022-3476(74)80455-5. [DOI] [PubMed] [Google Scholar]
  38. Lennon J. L., Black F. L. Maternally derived measles immunity in era of vaccine-protected mothers. J Pediatr. 1986 May;108(5 Pt 1):671–676. doi: 10.1016/s0022-3476(86)81039-3. [DOI] [PubMed] [Google Scholar]
  39. Lepage P., Dabis F., Msellati P., Hitimana D. G., Stevens A. M., Mukamabano B., Van Goethem C., Van de Perre P. Safety and immunogenicity of high-dose Edmonston-Zagreb measles vaccine in children with HIV-1 infection. A cohort study in Kigali, Rwanda. Am J Dis Child. 1992 May;146(5):550–555. doi: 10.1001/archpedi.1992.02160170030011. [DOI] [PubMed] [Google Scholar]
  40. Lewis T., Osborn L. M., Lewis K., Brockert J., Jacobsen J., Cherry J. D. Influence of parental knowledge and opinions on 12-month diphtheria, tetanus, and pertussis vaccination rates. Am J Dis Child. 1988 Mar;142(3):283–286. doi: 10.1001/archpedi.1988.02150030053018. [DOI] [PubMed] [Google Scholar]
  41. Markowitz L. E., Orenstein W. A. Measles vaccines. Pediatr Clin North Am. 1990 Jun;37(3):603–625. doi: 10.1016/s0031-3955(16)36907-3. [DOI] [PubMed] [Google Scholar]
  42. Markowitz L. E., Preblud S. R., Fine P. E., Orenstein W. A. Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J. 1990 Feb;9(2):101–110. doi: 10.1097/00006454-199002000-00008. [DOI] [PubMed] [Google Scholar]
  43. Markowitz L. E., Sepulveda J., Diaz-Ortega J. L., Valdespino J. L., Albrecht P., Zell E. R., Stewart J., Zarate M. L., Bernier R. H. Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines. N Engl J Med. 1990 Mar 1;322(9):580–587. doi: 10.1056/NEJM199003013220903. [DOI] [PubMed] [Google Scholar]
  44. Marks J. S., Halpin T. J., Irvin J. J., Johnson D. A., Keller J. R. Risk factors associated with failure to receive vaccinations. Pediatrics. 1979 Sep;64(3):304–309. [PubMed] [Google Scholar]
  45. Marks J. S., Hayden G. F., Orenstein W. A. Methodologic issues in the evaluation of vaccine effectiveness: measles vaccine at 12 vs. 15 months. Am J Epidemiol. 1982 Sep;116(3):510–523. doi: 10.1093/oxfordjournals.aje.a113435. [DOI] [PubMed] [Google Scholar]
  46. Mast E. E., Berg J. L., Hanrahan L. P., Wassell J. T., Davis J. P. Risk factors for measles in a previously vaccinated population and cost-effectiveness of revaccination strategies. JAMA. 1990 Nov 21;264(19):2529–2533. [PubMed] [Google Scholar]
  47. Mathias R. G., Meekison W. G., Arcand T. A., Schechter M. T. The role of secondary vaccine failures in measles outbreaks. Am J Public Health. 1989 Apr;79(4):475–478. doi: 10.2105/ajph.79.4.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Matson D. O., Byington C., Canfield M., Albrecht P., Feigin R. D. Investigation of a measles outbreak in a fully vaccinated school population including serum studies before and after revaccination. Pediatr Infect Dis J. 1993 Apr;12(4):292–299. doi: 10.1097/00006454-199304000-00007. [DOI] [PubMed] [Google Scholar]
  49. McAleer W. J., Markus H. Z., McLean A. A., Buynak E. B., Hilleman M. R. Stability on storage at various temperatures of live measles, mumps and rubella virus vaccines in new stabilizer. J Biol Stand. 1980;8(4):281–287. doi: 10.1016/s0092-1157(80)80005-9. [DOI] [PubMed] [Google Scholar]
  50. McChesney M. B., Oldstone M. B. Virus-induced immunosuppression: infections with measles virus and human immunodeficiency virus. Adv Immunol. 1989;45:335–380. doi: 10.1016/s0065-2776(08)60696-3. [DOI] [PubMed] [Google Scholar]
  51. McLean A. R., Anderson R. M. Measles in developing countries. Part II. The predicted impact of mass vaccination. Epidemiol Infect. 1988 Jun;100(3):419–442. doi: 10.1017/s0950268800067170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Murphy M. D., Brunell P. A., Lievens A. W., Shehab Z. M. Effect of early immunization on antibody response to reimmunization with measles vaccine as demonstrated by enzyme-linked immunosorbent assay (ELISA). Pediatrics. 1984 Jul;74(1):90–93. [PubMed] [Google Scholar]
  53. Mäkelä M. J., Marusyk R. G., Norrby E., Tyrrell D. L., Salmi A. A. Antibodies to measles virus surface polypeptides in an immunized student population before and after booster vaccination. Vaccine. 1989 Dec;7(6):541–545. doi: 10.1016/0264-410x(89)90279-x. [DOI] [PubMed] [Google Scholar]
  54. Nkowane B. M., Bart S. W., Orenstein W. A., Baltier M. Measles outbreak in a vaccinated school population: epidemiology, chains of transmission and the role of vaccine failures. Am J Public Health. 1987 Apr;77(4):434–438. doi: 10.2105/ajph.77.4.434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Ofosu-Amaah S. The control of measles in tropical Africa: a review of past and present efforts. Rev Infect Dis. 1983 May-Jun;5(3):546–553. doi: 10.1093/clinids/5.3.546. [DOI] [PubMed] [Google Scholar]
  56. Orenstein W. A., Markowitz L., Preblud S. R., Hinman A. R., Tomasi A., Bart K. J. Appropriate age for measles vaccination in the United States. Dev Biol Stand. 1986;65:13–21. [PubMed] [Google Scholar]
  57. Raddish M., Goldmann D. A., Kaplan L. C., Perrin J. M. The immunization status of children with spina bifida. Am J Dis Child. 1993 Aug;147(8):849–853. doi: 10.1001/archpedi.1993.02160320051018. [DOI] [PubMed] [Google Scholar]
  58. Reynolds D. W., Stagno S., Herrman K. L., Alford C. A. Antibody response to live virus vaccines in congenital and neonatal cytomegalovirus infections. J Pediatr. 1978 May;92(5):738–742. doi: 10.1016/s0022-3476(78)80140-1. [DOI] [PubMed] [Google Scholar]
  59. Robertson S. E., Markowitz L. E., Berry D. A., Dini E. F., Orenstein W. A. A million dollar measles outbreak: epidemiology, risk factors, and a selective revaccination strategy. Public Health Rep. 1992 Jan-Feb;107(1):24–31. [PMC free article] [PubMed] [Google Scholar]
  60. Robinson C. A., Sepe S. J., Lin K. F. The president's child immunization initiative--a summary of the problem and the response. Public Health Rep. 1993 Jul-Aug;108(4):419–425. [PMC free article] [PubMed] [Google Scholar]
  61. Shasby D. M., Shope T. C., Downs H., Herrmann K. L., Polkowski J. Epidemic measles in a highly vaccinated population. N Engl J Med. 1977 Mar 17;296(11):585–589. doi: 10.1056/NEJM197703172961102. [DOI] [PubMed] [Google Scholar]
  62. Sherrod J. L., Kane R., Cherry J. D., Fricker J., Maples K. Effect of timing of measles vaccination on compliance with immunizations during the second year of life. J Pediatr. 1983 Feb;102(2):186–190. doi: 10.1016/s0022-3476(83)80516-2. [DOI] [PubMed] [Google Scholar]
  63. Solis J. M., Marks G., Garcia M., Shelton D. Acculturation, access to care, and use of preventive services by Hispanics: findings from HHANES 1982-84. Am J Public Health. 1990 Dec;80 (Suppl):11–19. doi: 10.2105/ajph.80.suppl.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Szilagyi P. G., Rodewald L. E., Humiston S. G., Raubertas R. F., Cove L. A., Doane C. B., Lind P. H., Tobin M. S., Roghmann K. J., Hall C. B. Missed opportunities for childhood vaccinations in office practices and the effect on vaccination status. Pediatrics. 1993 Jan;91(1):1–7. [PubMed] [Google Scholar]
  65. Valdez R. B., Morgenstern H., Brown R., Wyn R., Wang C., Cumberland W. Insuring Latinos against the costs of illness. JAMA. 1993 Feb 17;269(7):889–894. [PubMed] [Google Scholar]
  66. Wyll S. A., Witte J. J. Measles in previously vaccinated children. An epidemiological study. JAMA. 1971 May 24;216(8):1306–1310. [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES